Clinical lipidology: a companion to Braunwald's heart disease
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Philadelphia
Elsevier
[2024]
|
| Ausgabe: | Edition 3 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Klappentext |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | xxii, 405 Seiten Illustrationen, Diagramme |
| ISBN: | 9780323882866 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV048838072 | ||
| 003 | DE-604 | ||
| 005 | 20240209 | ||
| 007 | t | ||
| 008 | 230301s2024 a||| |||| 00||| eng d | ||
| 020 | |a 9780323882866 |9 978-0-323-88286-6 | ||
| 035 | |a (OCoLC)1374564566 | ||
| 035 | |a (DE-599)BVBBV048838072 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-384 |a DE-578 | ||
| 084 | |a YC 7401 |0 (DE-625)153255:12907 |2 rvk | ||
| 084 | |a QU 260.5.L5 |2 nlm | ||
| 100 | 1 | |a Ballantyne, Christie M. |d ca. 20./21. Jh. |e Verfasser |0 (DE-588)1284496376 |4 aut | |
| 245 | 1 | 0 | |a Clinical lipidology |b a companion to Braunwald's heart disease |c Christie M. Ballantyne, MD |
| 250 | |a Edition 3 | ||
| 264 | 1 | |a Philadelphia |b Elsevier |c [2024] | |
| 264 | 4 | |c © 2024 | |
| 300 | |a xxii, 405 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 0 | 7 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 856 | 4 | 2 | |m Digitalisierung UB Augsburg - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034103557&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Digitalisierung UB Augsburg - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034103557&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034103557 | ||
Datensatz im Suchindex
| _version_ | 1804184946437259264 |
|---|---|
| adam_text | Contents ■ECTION I INTRODUCTION/BASIC MECHANISMS Overview of Lipids and Atherosclerosis, 1 1 PETER LIBBY 12 Treatment Guidelines Overview: American Heart Association/American College of Cardiology/Multisociety Guideline and Updates, 101 KAROL WATSON, SALIM S. VIRANI, AND NEIL J. STONE CTION II 2 RISK ASSESSMENT Overview of Risk Assessment, 17 13 Treatment Guidelines Overview: European Society of Cardiology/European Atherosclerosis Society Guidelines, 113 MATTHEW R. DESHOTELSAND CHRISTIE Μ. BALLANTYNE 3 Measurement of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Low-Density Lipoprotein Particle Concentration, 21 SAMIA MORA AND SETH S. MARTIN 4 Triglycerides, Triglyceride-Rich Lipoproteins, and High-Density Lipoprotein in Coronary Heart Disease Risk Assessment, 32 ANNE TYBJÆRG-HANSEN AND BØRGE GRØNNE NORDESTGAARD 5 Lipoprotein(a) in Cardiovascular Risk Assessment, 42 MICHAEL B. BOFFA, MARLYS L KOSCHINSKY, AND SANTICA M. ALBERICO L. CATAPANO 14 ANN C. SKULAS-RAY, CHESNEY RICHTER, DANIELLE CUMMINGS, AND PENNY Μ. KRIS-ETHERTON 15 Clinical Evaluation for Genetic Testing and Secondary Causes of Dyslipidemia, 54 ROBERTA. HEGELE 7 LAVIE 16 8 9 17 18 Cholesterol Absorption Inhibitors, 161 GIUSEPPE D. NORATA AND ALBERICO L. CATAPANO 19 Omega-3 Fatty Acids, 169 NICKPREET SINGH, ERIK DOVE, AND DEEPAK L. BHATT High-Sensitivity С-Reactive Protein, 69 Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition, 184 DAVID I. FELDMAN, ROGER S. BLUMENTHAL, AND TY J. GLUCKMAN NICHOLASA. MARSTON AND MARC S. SABATINE Emerging Assays for Risk
Assessment, 79 Imaging Atherosclerosis for Risk Stratification: Cardiac Computed Tomography and Carotid Ultrasound, 88 ALI Μ. AGHA AND VIJAY NAMBI SECTION III 11 Statins, 154 LALE TOKGÖZOĞLU, CARL ORRINGER, AND JOSEPH J. SASEEN 20 21 THERAPY Overview of General Approach to Management of Dyslipidemias, 97 VIJAY NAMBI, CHRISTIE Μ. BALLANTYNE, AND PETER H. JONES Inclisiran, 193 JULIA BRANDTS AND KAUSIK K. RAY RON C. HOOGEVEEN AND CHRISTIE Μ. BALLANTYNE 10 Obesity, Lipids, and Cardiovascular Disease, 141 HAROLD EDWARD BAYS, LYDIA C. ALEXANDER, AND ANGELA FITCH Polygenic Risk Scores, 62 BRIAN T. PALMISANO AND JOSHUA W. KNOWLES Updated Clinical Guide to Exercise and Lipids, 132 MICHAEL VAUGHN F. MENDOZA, SERGEY M. KACHUR, AND CARL J. MARCOVINA 6 Dietary Patterns for the Prevention and Treatment of Cardiovascular Disease, 122 22 Bempedoic Acid, 205 ALBERICO L. CATAPANO 23 Pemafibrate: A New Selective Peroxisome Proliferator-Activated Receptor-a Modulator for Hypertriglyceridemia Management, 214 VISHNU PRIYA PULIPATI AND ELIOTA. BRINTON 24 Anti-inflammatory Therapy for Cardiovascular Disease, 224 PAUL Μ RIDKER xix
25 Nutraceuticals and Functional Foods for Cholesterol Reduction, 236 33 Special Patient Populations: Children and Adolescents, 307 RACHEL J. SHUSTAK, JULIE A. BROTHERS, AND STEPHEN R. DA! DAVID J.A. JENKINS, LAURA CHIAVARGLI, ARASH MIRRAHIMI, KRISTIE SRICHAIKUL, JULIA Μ.W. WONG, PETER JONES, DARSHNA PATEL, CYRIL W.C. KENDALL, AND JOHN L. SIEVENPIPER 34 SECTION IV NEW AND EVOLVING THERAPEUTIC TARGETSAND PLATFORMS 26 Evolving Therapeutic Targets: Lipoprotein(a), 247 MAYA S. SAFAROVA, RAUL D. SANTOS, AND PATRICK Μ. MO! 35 LESLIE CHOAND STEVEN E. NISSEN 27 Inhibition of ANGPTL3 as a Target for Treating Dyslipidemias, 253 Evolving Therapeutic Targets: Apolipoprotein C-lll, 268 36 Evolving Therapeutic Targets: Cholesteryl Ester Transfer Protein Inhibition, 275 37 Gene Therapy and Therapeutic Genome Editing in Liver for Lipid Disorders, 281 ALAN G. JARDINE 38 31 39 HENRY N. GINSBERG 32 Special Patient Populations: Women and Older Adults, 298 ERIN D. MICHOS AND NANETTE K. WENGER Special Patient Populations: Lipid Abnormalities in High-Risk Racial/Ethr Groups, 375 RACHEL Μ. BOND AND KEITH C. FERDINAND SPECIAL PATIENT POPULATIONS Special Patient Populations: Diabetes and Metabolic Syndrome, 287 Special Populations: Chronic Kidney Disease, 367 PATRICK B. MARK, ALAN G. JARDINE, AND RAJAN K. PATEL DANIEL J. RADER SECTION V Special Patient Populations: Transplant Recipients, 358 JON A. KOBASHIGAWA, BENGT FELLSTRÖM, PATRICK B. MA՛ STEPHEN J. NICHOLLSANDADAM J. NELSON 30 Special Patient Populations: Acute Cor Syndromes, 345 GREGORY G. SCHWARTZ ALIZA HUSSAIN AND CHRISTIE Μ. BALLANTYNE 29
Special Patient Populations: Treatment Familial Chylomicronemia Syndrome a Sustained Chylomicronemia, 336 DANIEL GAUDET GERALD F. WATTS, DICK C. CHAN, AND FREDERICK J. RAAL 28 Special Patient Populations: Familial Hypercholesterolemia and Other Seven Hypercholesterolemias, 320 40 Persons With Human Immunodeficient Virus, 383 CARL J. FICHTENBAUM AND LAURA B. CHO Index, 391
CLINICAL LIPIDOLOGY A Companion to EDITION HEART DISEASE 3 CHRISTIE Μ. BALLANTYNE State-of-the-art, comprehensive coverage of lipidology from experts in the field. Part of the renowned Braunwald family of references, Clinical Lipidology: A Companion to Braunwald’s Heart Disease provides today’s clinicians with clear, authoritative guidance on the therapeutic management of patients with high cholesterol levels and other atherogenic lipid disorders. An invaluable resource for cardiologists, lipidologists, endocrinologists, and internal medicine physicians, this one-stop reference covers everything from basic science and the pathogenesis of atherothrombotic disease to risk assessment and the latest therapy options. Now fully updated from cover to cover, the 3rd Edition offers unparalleled coverage of lipidology in an accessible and user-friendly manner. • Thoroughly covers the assessment, diagnosis, and treatment of patients with elevated levels of lipids and lipoproteins, including all the latest research-based recommendations, therapeutic breakthroughs, and related clinical advances. • Presents the latest data on clinical guidelines, risk assessments, and established and emerging pharmacologic and nonpharmacologic therapies— all from internationally recognized experts in the field. • Features condensed, streamlined content that focuses on clinical applications and applying concepts to the practice setting. Chapters have now been completely reorganized into sections on risk assessment; therapy; new and evolving therapeutic targets and platforms; and special populations. •
Includes new chapters on Polygenic Risk Scores; Inclisiran; Bempedoic Acid; Selective Peroxisome Proliferator-Activated Receptor-a Modulator: Pemafibrate; Evolving Therapeutic Targets: Lp(a), ANGPTL3, and ApoC-lll; New Therapeutic Platforms: Gene Therapy and Genome Editing; and more. • Contains new or expanded content on inflammation; genetic testing; troponins for risk assessment; statins and role of bile acid séquestrants, niacin, and fibrates; mAbs; CANTOS and CIRT; colchicine; IL-6; and cellular, molecular, and genetic therapy. • Provides treatment algorithms throughout, as well as case vignettes that highlight the most common clinical questions in each chapter. • Incorporates the latest guidelines from the AHA, ACC, ESC, and EAS, as well as future directions for ongoing research and emerging applications. • An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.
|
| adam_txt |
Contents ■ECTION I INTRODUCTION/BASIC MECHANISMS Overview of Lipids and Atherosclerosis, 1 1 PETER LIBBY 12 Treatment Guidelines Overview: American Heart Association/American College of Cardiology/Multisociety Guideline and Updates, 101 KAROL WATSON, SALIM S. VIRANI, AND NEIL J. STONE CTION II 2 RISK ASSESSMENT Overview of Risk Assessment, 17 13 Treatment Guidelines Overview: European Society of Cardiology/European Atherosclerosis Society Guidelines, 113 MATTHEW R. DESHOTELSAND CHRISTIE Μ. BALLANTYNE 3 Measurement of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Low-Density Lipoprotein Particle Concentration, 21 SAMIA MORA AND SETH S. MARTIN 4 Triglycerides, Triglyceride-Rich Lipoproteins, and High-Density Lipoprotein in Coronary Heart Disease Risk Assessment, 32 ANNE TYBJÆRG-HANSEN AND BØRGE GRØNNE NORDESTGAARD 5 Lipoprotein(a) in Cardiovascular Risk Assessment, 42 MICHAEL B. BOFFA, MARLYS L KOSCHINSKY, AND SANTICA M. ALBERICO L. CATAPANO 14 ANN C. SKULAS-RAY, CHESNEY RICHTER, DANIELLE CUMMINGS, AND PENNY Μ. KRIS-ETHERTON 15 Clinical Evaluation for Genetic Testing and Secondary Causes of Dyslipidemia, 54 ROBERTA. HEGELE 7 LAVIE 16 8 9 17 18 Cholesterol Absorption Inhibitors, 161 GIUSEPPE D. NORATA AND ALBERICO L. CATAPANO 19 Omega-3 Fatty Acids, 169 NICKPREET SINGH, ERIK DOVE, AND DEEPAK L. BHATT High-Sensitivity С-Reactive Protein, 69 Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition, 184 DAVID I. FELDMAN, ROGER S. BLUMENTHAL, AND TY J. GLUCKMAN NICHOLASA. MARSTON AND MARC S. SABATINE Emerging Assays for Risk
Assessment, 79 Imaging Atherosclerosis for Risk Stratification: Cardiac Computed Tomography and Carotid Ultrasound, 88 ALI Μ. AGHA AND VIJAY NAMBI SECTION III 11 Statins, 154 LALE TOKGÖZOĞLU, CARL ORRINGER, AND JOSEPH J. SASEEN 20 21 THERAPY Overview of General Approach to Management of Dyslipidemias, 97 VIJAY NAMBI, CHRISTIE Μ. BALLANTYNE, AND PETER H. JONES Inclisiran, 193 JULIA BRANDTS AND KAUSIK K. RAY RON C. HOOGEVEEN AND CHRISTIE Μ. BALLANTYNE 10 Obesity, Lipids, and Cardiovascular Disease, 141 HAROLD EDWARD BAYS, LYDIA C. ALEXANDER, AND ANGELA FITCH Polygenic Risk Scores, 62 BRIAN T. PALMISANO AND JOSHUA W. KNOWLES Updated Clinical Guide to Exercise and Lipids, 132 MICHAEL VAUGHN F. MENDOZA, SERGEY M. KACHUR, AND CARL J. MARCOVINA 6 Dietary Patterns for the Prevention and Treatment of Cardiovascular Disease, 122 22 Bempedoic Acid, 205 ALBERICO L. CATAPANO 23 Pemafibrate: A New Selective Peroxisome Proliferator-Activated Receptor-a Modulator for Hypertriglyceridemia Management, 214 VISHNU PRIYA PULIPATI AND ELIOTA. BRINTON 24 Anti-inflammatory Therapy for Cardiovascular Disease, 224 PAUL Μ RIDKER xix
25 Nutraceuticals and Functional Foods for Cholesterol Reduction, 236 33 Special Patient Populations: Children and Adolescents, 307 RACHEL J. SHUSTAK, JULIE A. BROTHERS, AND STEPHEN R. DA!' DAVID J.A. JENKINS, LAURA CHIAVARGLI, ARASH MIRRAHIMI, KRISTIE SRICHAIKUL, JULIA Μ.W. WONG, PETER JONES, DARSHNA PATEL, CYRIL W.C. KENDALL, AND JOHN L. SIEVENPIPER 34 SECTION IV NEW AND EVOLVING THERAPEUTIC TARGETSAND PLATFORMS 26 Evolving Therapeutic Targets: Lipoprotein(a), 247 MAYA S. SAFAROVA, RAUL D. SANTOS, AND PATRICK Μ. MO! 35 LESLIE CHOAND STEVEN E. NISSEN 27 Inhibition of ANGPTL3 as a Target for Treating Dyslipidemias, 253 Evolving Therapeutic Targets: Apolipoprotein C-lll, 268 36 Evolving Therapeutic Targets: Cholesteryl Ester Transfer Protein Inhibition, 275 37 Gene Therapy and Therapeutic Genome Editing in Liver for Lipid Disorders, 281 ALAN G. JARDINE 38 31 39 HENRY N. GINSBERG 32 Special Patient Populations: Women and Older Adults, 298 ERIN D. MICHOS AND NANETTE K. WENGER Special Patient Populations: Lipid Abnormalities in High-Risk Racial/Ethr Groups, 375 RACHEL Μ. BOND AND KEITH C. FERDINAND SPECIAL PATIENT POPULATIONS Special Patient Populations: Diabetes and Metabolic Syndrome, 287 Special Populations: Chronic Kidney Disease, 367 PATRICK B. MARK, ALAN G. JARDINE, AND RAJAN K. PATEL DANIEL J. RADER SECTION V Special Patient Populations: Transplant Recipients, 358 JON A. KOBASHIGAWA, BENGT FELLSTRÖM, PATRICK B. MA՛ STEPHEN J. NICHOLLSANDADAM J. NELSON 30 Special Patient Populations: Acute Cor Syndromes, 345 GREGORY G. SCHWARTZ ALIZA HUSSAIN AND CHRISTIE Μ. BALLANTYNE 29
Special Patient Populations: Treatment Familial Chylomicronemia Syndrome a Sustained Chylomicronemia, 336 DANIEL GAUDET GERALD F. WATTS, DICK C. CHAN, AND FREDERICK J. RAAL 28 Special Patient Populations: Familial Hypercholesterolemia and Other Seven Hypercholesterolemias, 320 40 Persons With Human Immunodeficient Virus, 383 CARL J. FICHTENBAUM AND LAURA B. CHO Index, 391
CLINICAL LIPIDOLOGY A Companion to EDITION HEART DISEASE 3 CHRISTIE Μ. BALLANTYNE State-of-the-art, comprehensive coverage of lipidology from experts in the field. Part of the renowned Braunwald family of references, Clinical Lipidology: A Companion to Braunwald’s Heart Disease provides today’s clinicians with clear, authoritative guidance on the therapeutic management of patients with high cholesterol levels and other atherogenic lipid disorders. An invaluable resource for cardiologists, lipidologists, endocrinologists, and internal medicine physicians, this one-stop reference covers everything from basic science and the pathogenesis of atherothrombotic disease to risk assessment and the latest therapy options. Now fully updated from cover to cover, the 3rd Edition offers unparalleled coverage of lipidology in an accessible and user-friendly manner. • Thoroughly covers the assessment, diagnosis, and treatment of patients with elevated levels of lipids and lipoproteins, including all the latest research-based recommendations, therapeutic breakthroughs, and related clinical advances. • Presents the latest data on clinical guidelines, risk assessments, and established and emerging pharmacologic and nonpharmacologic therapies— all from internationally recognized experts in the field. • Features condensed, streamlined content that focuses on clinical applications and applying concepts to the practice setting. Chapters have now been completely reorganized into sections on risk assessment; therapy; new and evolving therapeutic targets and platforms; and special populations. •
Includes new chapters on Polygenic Risk Scores; Inclisiran; Bempedoic Acid; Selective Peroxisome Proliferator-Activated Receptor-a Modulator: Pemafibrate; Evolving Therapeutic Targets: Lp(a), ANGPTL3, and ApoC-lll; New Therapeutic Platforms: Gene Therapy and Genome Editing; and more. • Contains new or expanded content on inflammation; genetic testing; troponins for risk assessment; statins and role of bile acid séquestrants, niacin, and fibrates; mAbs; CANTOS and CIRT; colchicine; IL-6; and cellular, molecular, and genetic therapy. • Provides treatment algorithms throughout, as well as case vignettes that highlight the most common clinical questions in each chapter. • Incorporates the latest guidelines from the AHA, ACC, ESC, and EAS, as well as future directions for ongoing research and emerging applications. • An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Ballantyne, Christie M. ca. 20./21. Jh |
| author_GND | (DE-588)1284496376 |
| author_facet | Ballantyne, Christie M. ca. 20./21. Jh |
| author_role | aut |
| author_sort | Ballantyne, Christie M. ca. 20./21. Jh |
| author_variant | c m b cm cmb |
| building | Verbundindex |
| bvnumber | BV048838072 |
| classification_rvk | YC 7401 |
| ctrlnum | (OCoLC)1374564566 (DE-599)BVBBV048838072 |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| edition | Edition 3 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01801nam a2200385 c 4500</leader><controlfield tag="001">BV048838072</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240209 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">230301s2024 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780323882866</subfield><subfield code="9">978-0-323-88286-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1374564566</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048838072</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 7401</subfield><subfield code="0">(DE-625)153255:12907</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QU 260.5.L5</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ballantyne, Christie M.</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1284496376</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical lipidology</subfield><subfield code="b">a companion to Braunwald's heart disease</subfield><subfield code="c">Christie M. Ballantyne, MD</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Edition 3</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia</subfield><subfield code="b">Elsevier</subfield><subfield code="c">[2024]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2024</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxii, 405 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Augsburg - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034103557&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Augsburg - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034103557&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034103557</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV048838072 |
| illustrated | Illustrated |
| index_date | 2024-07-03T21:36:50Z |
| indexdate | 2024-07-10T09:47:25Z |
| institution | BVB |
| isbn | 9780323882866 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034103557 |
| oclc_num | 1374564566 |
| open_access_boolean | |
| owner | DE-384 DE-578 |
| owner_facet | DE-384 DE-578 |
| physical | xxii, 405 Seiten Illustrationen, Diagramme |
| publishDate | 2024 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| publisher | Elsevier |
| record_format | marc |
| spelling | Ballantyne, Christie M. ca. 20./21. Jh. Verfasser (DE-588)1284496376 aut Clinical lipidology a companion to Braunwald's heart disease Christie M. Ballantyne, MD Edition 3 Philadelphia Elsevier [2024] © 2024 xxii, 405 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index Lipidstoffwechselstörung (DE-588)4035876-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Lipidstoffwechselstörung (DE-588)4035876-8 s DE-604 Digitalisierung UB Augsburg - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034103557&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Augsburg - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034103557&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
| spellingShingle | Ballantyne, Christie M. ca. 20./21. Jh Clinical lipidology a companion to Braunwald's heart disease Lipidstoffwechselstörung (DE-588)4035876-8 gnd |
| subject_GND | (DE-588)4035876-8 (DE-588)4143413-4 |
| title | Clinical lipidology a companion to Braunwald's heart disease |
| title_auth | Clinical lipidology a companion to Braunwald's heart disease |
| title_exact_search | Clinical lipidology a companion to Braunwald's heart disease |
| title_exact_search_txtP | Clinical lipidology a companion to Braunwald's heart disease |
| title_full | Clinical lipidology a companion to Braunwald's heart disease Christie M. Ballantyne, MD |
| title_fullStr | Clinical lipidology a companion to Braunwald's heart disease Christie M. Ballantyne, MD |
| title_full_unstemmed | Clinical lipidology a companion to Braunwald's heart disease Christie M. Ballantyne, MD |
| title_short | Clinical lipidology |
| title_sort | clinical lipidology a companion to braunwald s heart disease |
| title_sub | a companion to Braunwald's heart disease |
| topic | Lipidstoffwechselstörung (DE-588)4035876-8 gnd |
| topic_facet | Lipidstoffwechselstörung Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034103557&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034103557&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT ballantynechristiem clinicallipidologyacompaniontobraunwaldsheartdisease |